Randomized clinical field trial of a bacterial kidney disease vaccine in Atlantic salmon, Salmo salar L.

Journal of Fish Diseases

Volumn 33, Issue 7, 2010, Pages 545-557

  Burnley, T A ^a   Stryhn, H ^a   Burnley, H J ^a   Hammell, K L ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Atlantic salmon; Bacterial kidney disease; Field trial; Survival analysis; Vaccine; Vaccine efficacy

Indexed keywords

BACTERIAL VACCINE;

ACTINOMYCETALES INFECTION; ANIMAL; ANIMAL DISEASE; ARTICLE; ATLANTIC SALMON; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FISH DISEASE; KAPLAN MEIER METHOD; MICROCOCCACEAE; MORTALITY; PHYSIOLOGY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; ACTINOMYCETALES INFECTIONS; FISH DISEASES; VETERINARY;

ACTINOMYCETALES INFECTIONS; ANIMALS; BACTERIAL VACCINES; FISH DISEASES; KAPLAN-MEIERS ESTIMATE; MICROCOCCACEAE; PREVALENCE; SALMO SALAR; KAPLAN-MEIER ESTIMATE;

BACTERIA (MICROORGANISMS); SALMO SALAR;

EID: 77954730222     PISSN: 01407775     EISSN: 13652761     Source Type: Journal    
DOI: 10.1111/j.1365-2761.2010.01151.x     Document Type: Article

References (13)

1. Alcorn S, Murray AL, Pascho RJ, Varney J. A cohabitation challenge to compare the efficacies of vaccines for bacterial kidney disease (BKD) in Chinook salmon Oncorhynchus tshawytscha. Diseases of Aquatic Organisms 2005, 63:151-160.
2. Amend DF. Potency testing of fish vaccines. Fish Biologic: Serodiagnostics and Vaccines: Developments in Biological Standardisation 1981, 49:447-454. Anderson DPHennessen H. in, ed. by
3. Balfry SK, Albright LJ, Evelyn TPT. Horizontal transfer of Renibacterium salmoninarum among farmed salmonids via the fecal-oral route. Diseases of Aquatic Organisms 1996, 25:63-69.
4. Bruno DW. Histopathology of bacterial kidney disease in laboratory infected rainbow trout, Salmo gairdneri Richardson, and Atlantic salmon, Salmo salar L., with reference to naturally infected fish. Journal of Fish Diseases 1986, 9:523-537.
5. Dohoo IR, Martin SW, Stryhn H. Veterinary Epidemiologic Research 2003, AVC Inc., Charlottetown, PE, Canada
6. Gjedrem T, Salte R, Gjoen HM. Genetic variation in susceptibility of Atlantic salmon to furunculosis. Aquaculture 1991, 97:1-6.
7. Gutenberger SK, Dumistra JR, Rohovec JS, Fryer JL. Intracellular survival of Renibacterium salmoninarum in trout mononuclear phagocytes. Diseases of Aquatic Organisms 1997, 28:93-106.
8. John TJ, Samuel R. Herd immunity and herd effects: new insights and definitions. European Journal of Epidemiology 2000, 16:601-606.
9. Lillehaug A, Lunder T, Poppe TT. Field testing of adjuvanted furunculosis vaccines in Atlantic salmon, Salmo salar L. Journal of Fish Diseases 1992, 15:485-496.
10. Midtlyng PJ, Reitan LJ, Lillehaug A, Ramstad A. Protection, immune responses and side effects in Atlantic salmon (Salmo salar L.) vaccinated against furunculosis by different procedures. Fish & Shellfish Immunology 1996, 6:599-613.
11. Ramstad A, Romstad AB, Knappskog DH, Midtlyng PJ. Field validation of experimental challenge models for IPN vaccines. Journal of Fish Diseases 2007, 30:723-731.
12. Rhodes LD, Rathbone CK, Corbett SC, Harrell LW, Strom MS. Efficacy of cellular vaccines and genetic adjuvants against bacterial kidney disease in Chinook salmon (Oncorhynchus tshawytscha). Fish & Shellfish Immunology 2004, 16:461-474.
13. Standal M, Gjerde B. Genetic variation in survival of Atlantic salmon during the sea-rearing period. Aquaculture 1987, 66:197-207.